[HTML][HTML] Re-irradiation of adenoid cystic carcinoma: analysis and evaluation of outcome in 52 consecutive patients treated with raster-scanned carbon ion therapy

AD Jensen, M Poulakis, AV Nikoghosyan… - Radiotherapy and …, 2015 - Elsevier
Background Treatment of local relapse in adenoid cystic carcinoma (ACC) following prior
radiation remains a challenge: without the possibility of surgical salvage patients face the …

Molecular targets in salivary gland cancers: a comprehensive genomic analysis of 118 mucoepidermoid carcinoma tumors

M Bou Zerdan, PA Kumar, D Zaccarini, J Ross… - Biomedicines, 2023 - mdpi.com
Introduction: Salivary gland carcinomas (SGC) are histologically diverse cancers and next-
generation sequencing (NGS) to identify key molecular targets is an important aspect in the …

Outcomes of postoperative concurrent chemoradiotherapy for locally advanced major salivary gland carcinoma

T Tanvetyanon, D Qin, T Padhya… - … –Head & Neck …, 2009 - jamanetwork.com
Objective To investigate the potential value of postoperative concurrent chemoradiation
among patients with high-risk salivary gland carcinomas. Design Case control study based …

Epithelial tumours of the lacrimal gland: a clinical, histopathological, surgical and oncological survey

SL von Holstein, SE Coupland, D Briscoe… - Acta …, 2013 - Wiley Online Library
Epithelial tumours of the lacrimal gland represent a large spectrum of lesions with
similarities in clinical signs and symptoms but with different biological behaviour and …

A rationale for chemoradiation (vs radiotherapy) in salivary gland cancers? On behalf of the REFCOR (French rare head and neck cancer network)

T Cerda, XS Sun, S Vignot, PY Marcy, B Baujat… - Critical reviews in …, 2014 - Elsevier
Background Salivary gland carcinomas constitute a heterogeneous group of tumors, with
over 20 histological subtypes of various prognoses. The mainstay of treatment is surgery …

Molecular biology and therapeutic targets of primitive tracheal tumors: focus on tumors derived by salivary glands and squamous cell carcinoma

A Marchioni, R Tonelli, AV Samarelli… - International Journal of …, 2023 - mdpi.com
Primary tracheal tumors are rare, constituting approximately 0.1–0.4% of malignant
diseases. Squamous cell carcinoma (SCC) and adenoid cystic carcinoma (ACC) account for …

The therapeutic landscape of salivary gland malignancies—where are we now?

R Cleymaet, T Vermassen, R Coopman… - International Journal of …, 2022 - mdpi.com
Salivary gland malignancies (SGMs) account for less than 5% of new diagnoses in head
and neck tumors. If feasible, surgery is the preferred treatment modality. Nevertheless, some …

An overview of the rare parotid gland cancer

K Ho, H Lin, DK Ann, PG Chu, Y Yen - Head & neck oncology, 2011 - Springer
Cancer of the parotid gland is relatively rare, but carries poor prognosis owing to its
prevailing distant metastases. In addition to the disease's basic epidemiology and …

Combination chemotherapy of carboplatin and paclitaxel for advanced/metastatic salivary gland carcinoma patients: differences in responses by different pathological …

K Nakano, Y Sato, T Sasaki, W Shimbashi… - Acta oto …, 2016 - Taylor & Francis
Background: A standard chemotherapy for recurrent/metastatic salivary gland cancers has
not been established. Combination chemotherapy of carboplatin and paclitaxel should be …

Cephaeline is an inductor of histone H3 acetylation and inhibitor of mucoepidermoid carcinoma cancer stem cells

LC Silva, GB Borgato, VP Wagner… - Journal of Oral …, 2022 - Wiley Online Library
Aim To evaluate the potential use of Cephaeline as a therapeutic strategy to manage
mucoepidermoid carcinomas (MEC) of the salivary glands. Material and Methods UM‐HMC …